Chemotherapy-induced Circadian Rhythm Disruption

NCT04364347 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2022-05-05

No results posted yet for this study

Summary

The purpose of this study is to investigate chemotherapy-induced circadian rhythm disruption through biomarkers, and the relationship between chemotherapy-induced circadian rhythm disruptions and side effects of chemotherapy.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

Principal Investigators

  • Bong-Jin Hahm, M.D.,Ph.D. · Seoul National University Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-14
Primary Completion
2022-10-31
Completion
2023-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04364347 on ClinicalTrials.gov